BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 17643451)

  • 1. Japanese encephalitis revisited.
    Diagana M; Preux PM; Dumas M
    J Neurol Sci; 2007 Nov; 262(1-2):165-70. PubMed ID: 17643451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Japanese encephalitis: development of new candidate vaccines.
    Bharati K; Vrati S
    Expert Rev Anti Infect Ther; 2006 Apr; 4(2):313-24. PubMed ID: 16597211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
    Zhou B; Jia L; Xu X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Japanese encephalitis vaccines: moving away from the mouse brain.
    Zanin MP; Webster DE; Martin JL; Wesselingh SL
    Expert Rev Vaccines; 2003 Jun; 2(3):407-16. PubMed ID: 12903806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Japanese encephalitis for a reference to international travelers.
    Oya A; Kurane I
    J Travel Med; 2007; 14(4):259-68. PubMed ID: 17617849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological situation of Japanese encephalitis in Nepal.
    Bista MB; Shrestha JM
    JNMA J Nepal Med Assoc; 2005; 44(158):51-6. PubMed ID: 16554872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Japanese encephalitis vaccine for travelers: exploring the limits of risk.
    Shlim DR; Solomon T
    Clin Infect Dis; 2002 Jul; 35(2):183-8. PubMed ID: 12087525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan.
    Yang SE; Pan MJ; Tseng HF; Liau MY
    Vaccine; 2006 Mar; 24(14):2669-73. PubMed ID: 16314007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China.
    Ding D; Kilgore PE; Clemens JD; Wei L; Zhi-Yi X
    Bull World Health Organ; 2003; 81(5):334-42. PubMed ID: 12856051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A chimeric live attenuated vaccine against Japanese encephalitis.
    Jones T
    Expert Rev Vaccines; 2004 Jun; 3(3):243-8. PubMed ID: 15176941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost benefit analysis of Japanese encephalitis vaccination program in Thailand.
    Siraprapasiri T; Sawaddiwudhipong W; Rojanasuphot S
    Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):143-8. PubMed ID: 9322297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of the partial effects of inactivated Japanese encephalitis vaccination: analysis of previous outbreaks in Japan from 1953 to 1960.
    Satou K; Nishiura H
    Ann Epidemiol; 2007 Apr; 17(4):271-7. PubMed ID: 17300956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of SA14-14-2 live attenuated Japanese encephalitis vaccine against the wild-type JE viruses.
    Jia L; Wang Z; Yu Y
    Chin Med J (Engl); 2003 Jun; 116(6):941-3. PubMed ID: 12877812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ChimeriVax-JE. Acambis.
    Jones T
    Curr Opin Investig Drugs; 2003 Aug; 4(8):1019-22. PubMed ID: 14508887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Japanese encephalitis globally and in India.
    Jacobson J; Sivalenka S
    Indian J Public Health; 2004; 48(2):49-56. PubMed ID: 15709584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. drjbtandan@yahoo.com.
    Tandan JB; Ohrr H; Sohn YM; Yoksan S; Ji M; Nam CM; Halstead SB
    Vaccine; 2007 Jun; 25(27):5041-5. PubMed ID: 17521781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroepidemiology study of Japanese encephalitis neutralizing antibodies in southern Taiwan: a comparative study between urban city and country townships.
    Tseng HF; Tan HF; Chang CK; Huang WL; Ho WC
    Am J Infect Control; 2003 Nov; 31(7):435-40. PubMed ID: 14639442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine.
    Beasley DW; Li L; Suderman MT; Guirakhoo F; Trent DW; Monath TP; Shope RE; Barrett AD
    Vaccine; 2004 Sep; 22(27-28):3722-6. PubMed ID: 15315852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Japanese encephalitis epidemic in Western Nepal in 1997.
    Akiba T; Osaka K; Tang S; Nakayama M; Yamamoto A; Kurane I; Okabe N; Umenai T
    Epidemiol Infect; 2001 Feb; 126(1):81-8. PubMed ID: 11293685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of yearly changes in levels of antibodies to Japanese encephalitis virus nonstructural 1 protein in racehorses in central Japan shows high levels of natural virus activity still exist.
    Konishi E; Shoda M; Kondo T
    Vaccine; 2006 Jan; 24(4):516-24. PubMed ID: 16129523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.